Pacira BioSciences (PCRX) Assets Average (2011 - 2026)

Pacira BioSciences' Assets Average history runs 16 years deep, the most recent figure standing at $1.2 billion for Q1 2026.

• In Q1 2026, Assets Average fell 21.23% year-over-year to $1.2 billion; the TTM figure through Mar 2026 stood at $1.2 billion (down 21.23% YoY), while the FY2025 annual figure was $1.4 billion, down 9.89% from the prior year.
• Assets Average was $1.2 billion for Q1 2026 at Pacira BioSciences, down from $1.3 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $2.0 billion in Q1 2022 to a low of $1.2 billion in Q1 2026.
• Historically, Assets Average has averaged $1.6 billion across 5 years, with a median of $1.6 billion in 2025.
• The sharpest annual moves came in 2022 and 2026: Assets Average surged 54.83% in 2022, then dropped 21.23% in 2026.
• A 5-year view of Assets Average shows it stood at $1.7 billion in 2022, then declined by 8.98% to $1.6 billion in 2023, then retreated by 1.08% to $1.5 billion in 2024, then retreated by 16.67% to $1.3 billion in 2025, then slipped by 3.47% to $1.2 billion in 2026.
• The last three Assets Average figures came in at $1.2 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.4 billion (Q3 2025), per Business Quant data.